Dr. Scott A. Kono, assistant professor of hematology and medical oncology, who serves as principal investigator or co-investigator on several head and neck cancer clinical trials at Winship.
“You can get standard treatment anywhere, but only certain centers, such as the NCI-designated Winship Cancer Institute, emphasize basic science research and cutting-edge clinical trial development,” said Dr. Kono. “Learning more about the biology of these diseases will lead to more effective therapy, such as targeted treatments, and ultimately improve outcomes for patients.”
Dr. Kono earned his medical degree at Midwestern University. He completed his internal medicine residency at the University of Kansas Medical Center, followed by a fellowship in hematology and medical oncology at the University of Colorado before joining Emory University. He has an interest in teaching and program development, which was reflected by his service as both chief resident and chief fellow in his respective training programs.
“Dr. Kono’s innovative research and his role in our lung and aerodigestive cancer clinical trials offer new hope for patients with these difficult cancers,” said Dr. Fadlo R. Khuri. “We are grateful for the public and private support that allows us to recruit and retain talented investigators.”
Home| Contact Health Sciences| Emergen
|